Incannex Healthcare (IXHL) Current Deferred Revenue (2021 - 2026)
Incannex Healthcare (IXHL) posted Current Deferred Revenue of $30000.0 for Q1 2026, little changed sequentially from $30000.0 in Q4 2025, and up 7.14% YoY from $28000.0 in Q1 2025.
Incannex Healthcare (IXHL) Current Deferred Revenue (2021 - 2026) Analysis & Trends
Incannex Healthcare has reported Current Deferred Revenue for 6 years, with the latest figure at $30000.0 in Q1 2026.
- Quarterly Current Deferred Revenue rose 7.14% year-over-year to $30000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30000.0 (up 7.14% YoY) and the FY2025 annual result came in at $30000.0, down 64.71% from the prior year.
- Current Deferred Revenue held at $30000.0 in Q1 2026 per IXHL's latest filing, from $30000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $3.7 million in Q2 2023 and troughed at $27000.0 in Q4 2024.
- A 5-year average of $582261.7 and a median of $30000.0 in 2025 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2022 and 2024: Current Deferred Revenue soared 197.4% in 2022, then sank 97.69% in 2024.
- Over 5 years, Current Deferred Revenue stood at $1.8 million in 2022, then soared by 100.99% to $3.7 million in 2023, then tumbled by 99.27% to $27000.0 in 2024, then rose by 11.11% to $30000.0 in 2025, then changed by 0.0% to $30000.0 in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $30000.0, $30000.0, and $30000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Incannex Healthcare | 42.23 Mn | 42.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 59,000.00 |
| Jun 30, 2024 | 85,000.00 |
| Jun 30, 2023 | 3.68 Mn |
| Jun 30, 2022 | 1.83 Mn |
| Jun 30, 2021 | 614,834.00 |